[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559570":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":34,"centralContacts":38,"locations":44,"responsibleParty":61,"collaborators":10,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"First Affiliated Hospital of Harbin Medical University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"surgery group",null,"The patients underwent surgery",[13],"Procedure: Surgery",{"label":15,"type":10,"description":16,"interventionNames":17},"triple anti-tuberculosis drug therapy group","The patients were treated with triple anti-tuberculosis drugs",[18],"Drug: triple anti-tuberculosis drug",{"label":20,"type":10,"description":21,"interventionNames":22},"combination therapy group","The patients were treated with surgery first, and then took triple anti-tuberculosis drugs after surgery",[13,18],[24,29],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"PROCEDURE","Surgery","patients underwent complete excision of the inflammatory breast tissue and some surrounding normal tissue under combined intravenous with inhalation anesthesia. Damaged skin was also removed.",[20,9],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"DRUG","triple anti-tuberculosis drug","Patients took oral rifampin (450 mg\u002Fday), isoniazid (300 mg\u002Fday), and ethambutol (15 mg\u002Fkg\u002Fday).",[20,15],[35],{"name":36,"affiliation":5,"role":37},"Jing Feng","STUDY_DIRECTOR",[39],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Yi Zhou","CONTACT","+86-0451-85552102","lubj2001@163.com",[45],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"First affiliated hospital of Harbin medical university","RECRUITING","Harbin","Heilongjiang","150001","China","CN",{"type":54,"coordinates":55},"Point",[56,57],126.65,45.75,{"lat":57,"lon":56},[60],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100559570","analysis-of-various-treatment-methods-of-granulomatous-lobular-mastitis-100559570",false,"NCT06565845","Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis","Analysis of the Clinical Characteristics and Three Treatment Methods of Granulomatous Lobular Mastitis","Inclusion Criteria:\n\n* non-lactating and aged 15-65 years\n* histopathological confirmation of GLM\n* normal liver and kidney function\n\nExclusion Criteria:\n\n* lactating and pregnant women\n* allergies to rifampin, isoniazid, or ethambutol\n* concurrent malignant breast tumors\n* severe underlying diseases\n* other conditions deemed unsuitable by the investigator and\n* refusal to participate in the study","FEMALE","15 Years","65 Years",{"count":74,"type":75},350,"ESTIMATED","OBSERVATIONAL","Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.",[79],"Granulomatous Mastitis",[81,82,83,84],"Granulomatous lobular mastitis","surgical treatment","antituberculosis therapy","surgery combined with anti-tuberculosis therapy","2024-08-21",{"date":87,"type":88},"2024-08-22","ACTUAL",{"date":90,"type":88},"2024-08-19",{"date":92,"type":75},"2024-10-19",{"name":5,"class":6},1]